Low value of detection of KRAS2 mutations in circulating DNA to differentiate chronic pancreatitis to pancreatic cancer.
作者信息
Marchese R, Muleti A, Brozzetti S, Gandini O, Brunetti E, French D
出版信息
Br J Cancer. 2004 Jun 1;90(11):2243. doi: 10.1038/sj.bjc.6601854.
Abstract
摘要
相似文献
1
Low value of detection of KRAS2 mutations in circulating DNA to differentiate chronic pancreatitis to pancreatic cancer.
Br J Cancer. 2004 Jun 1;90(11):2243. doi: 10.1038/sj.bjc.6601854.
2
Differential diagnosis between chronic pancreatitis and pancreatic cancer: value of the detection of KRAS2 mutations in circulating DNA.
Br J Cancer. 2002 Aug 27;87(5):551-4. doi: 10.1038/sj.bjc.6600475.
3
Sensitive and quantitative detection of KRAS2 gene mutations in pancreatic duct juice differentiates patients with pancreatic cancer from chronic pancreatitis, potential for early detection.
Cancer Biol Ther. 2008 Mar;7(3):353-360. doi: 10.4161/cbt.7.3.5362.
4
Low correspondence between K-ras mutations in pancreatic cancer tissue and detection of K-ras mutations in circulating DNA.
Pancreas. 2006 Mar;32(2):171-7. doi: 10.1097/01.mpa.0000202938.63084.e3.
5
Kras mutation analysis of fine needle aspirate under EUS guidance facilitates risk stratification of patients with pancreatic mass.
J Clin Gastroenterol. 2007 Nov-Dec;41(10):906-10. doi: 10.1097/MCG.0b013e31805905e9.
6
K-ras mutations in circulating DNA from pancreatic and lung cancers: bridging methodology for a common validation of the molecular diagnosis value.
Pancreas. 2008 Jul;37(1):101-2. doi: 10.1097/MPA.0b013e31815e72bc.
7
Shining the spotlight on shed KRAS in pancreatic cancer.
Cancer Biol Ther. 2008 Mar;7(3):361-3. doi: 10.4161/cbt.7.3.5582.
8
Long-term follow-up of patients with chronic pancreatitis and K-ras gene mutation detected in pancreatic juice.
Gastroenterology. 1997 Aug;113(2):593-8. doi: 10.1053/gast.1997.v113.pm9247481.
9
Clinical significance of K-ras and c-erbB-2 mutations in pancreatic adenocarcinoma and chronic pancreatitis.
Int J Gastrointest Cancer. 2005;35(1):33-41. doi: 10.1385/IJGC:35:1:033.
10
Genetic and epigenetic markers in the evaluation of pancreatic masses.
J Clin Pathol. 2013 Mar;66(3):192-7. doi: 10.1136/jclinpath-2012-201123. Epub 2012 Nov 7.
引用本文的文献
1
The Use of Biomarkers in Early Diagnostics of Pancreatic Cancer.
Can J Gastroenterol Hepatol. 2018 Aug 14;2018:5389820. doi: 10.1155/2018/5389820. eCollection 2018.
2
Liquid biopsy in patients with pancreatic cancer: Circulating tumor cells and cell-free nucleic acids.
World J Gastroenterol. 2016 Jul 7;22(25):5627-41. doi: 10.3748/wjg.v22.i25.5627.
本文引用的文献
1
Differential diagnosis between chronic pancreatitis and pancreatic cancer: value of the detection of KRAS2 mutations in circulating DNA.
Br J Cancer. 2002 Aug 27;87(5):551-4. doi: 10.1038/sj.bjc.6600475.
2
Rapid detection of ras oncogenes in human tumors: applications to colon, esophageal, and gastric cancer.
Oncogene. 1989 Jul;4(7):923-8.
Zotero 插件